Pharmaceutisch Weekblad

, Volume 13, Issue 6, pp 244–247 | Cite as

Pharmaceuticals and developing countries: problems and prospects

  • D. C. Jayasuriya


For many decades there was little consensus on the nature and type of pharmaceutical policies best suited for developing countries. In the aftermath of the Nairobi Conference on the Rational Use of Drugs and the formulation of criteria by expert groups convened by the World Health Organization a consensus has emerged on many aspects. Infrastructure development and the deployment of trained manpower are now perceived as two of the essential requisites for the implementation of national pharmaceutical policies. The article reviews selected problem areas in the pharmaceuticals sector and proposes strategies to overcome them.


Developing countries Drug utilization Education, pharmacy Essential drugs Health facilities Health manpower Health policy World Health Organization 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Health Organization. The rational use of drugs. Geneva: World Health Organization, 1987.Google Scholar
  2. 2.
    Medwar C. International regulation of the supply and use of Pharmaceuticals. Dev Dial 1985;2:15–37.Google Scholar
  3. 3.
    World Health Organization. The world drug situation. Geneva: World Health Organization, 1988.Google Scholar
  4. 4.
    Richards T. Drugs in developing countries: inching towards rational policies. Br Med J 1986;292:1347–8.Google Scholar
  5. 5.
    Bakke OM. How many drugs do we need? World Health For 1986;7:252–5.Google Scholar
  6. 6.
    Jayasuriya DC. Regulation of drugs in developing countries. Legal issues and approaches. Geneva: World Health Organization, 1985.Google Scholar
  7. 7.
    DANIDA, SIDA. Quality control of drugs in Bangladesh. Copenhagen: DANIDA/SIDA, 1983.Google Scholar
  8. 8.
    Jayasuriya DC. Rational use of drugs and the Third World. Nawala: ICHPL, 1988.Google Scholar
  9. 9.
    Jayasuriya DC. The public health and economic dimensions of the new drug policy of Bangladesh. Washington: PMA, 1985.Google Scholar
  10. 10.
    WHO, DANIDA, SIDA. Report of a project preparation mission on essential drugs for primary health care in Bangladesh. Geneva: World Health Organization, 1984:12.Google Scholar
  11. 11.
    Nightingale SL, Morrison JC. Generic drugs and the prescribing physician. JAMA 1987;258(9):1200–4.CrossRefPubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1991

Authors and Affiliations

  • D. C. Jayasuriya
    • 1
  1. 1.Institute of Comparative Health Policy and LawNawalaSri Lanka

Personalised recommendations